Aachen, Germany (OTE) - Grünenthal announced today that the company has joined the Cluster for Nucleic Acid Therapeutics Munich (CNATM), a Munich-centred innovation network that brings together leading universities, research...
Aachen (OTE) - Grünenthal announced today that its investigational compound tegacorat (GRM-01) received Orphan Drug and Rare Pediatric Disease Designations from the US Food and Drug Administration (FDA) for the treatment...
Aachen (OTE) - Aachen (ots)
Aachen, Germany & Yeoju, South Korea (OTE) - Grünenthal, a global leader in pain management and related diseases, and BCWorld Pharm Co., Ltd. ("BCWP"), a specialty company actively expanding and diversifying its...
Aachen, Germany (OTE) - - Grünenthal acquired Kyowa Kirin International's 49% stake in 'Grünenthal Meds', a joint venture formed in 2023 to market the established medicines portfolio from Kyowa Kirin International....
Über das OTS-Mailabo erhalten Sie kostenlos alle Aussendungen des gewählten Aussenders per E-Mail - sofort bei Veröffentlichung oder als Tageszusammenfassung.
Über das OTS-Mailabo erhalten Sie kostenlos alle Aussendungen des gewählten Aussenders per E-Mail - sofort bei Veröffentlichung oder als Tageszusammenfassung.